Artikel ; Online: Daratumumab Use Prior to Kidney Transplant and T Cell-Mediated Rejection: A Case Report.
American journal of kidney diseases : the official journal of the National Kidney Foundation
2023 Band 81, Heft 5, Seite(n) 616–620
Abstract: There is growing interest in daratumumab in the solid organ transplant realm owing to the potential immunomodulatory effects on CD38-expressing cells, primarily plasma cells, as they have a key role in antibody production. In particular there is interest ...
| Abstract | There is growing interest in daratumumab in the solid organ transplant realm owing to the potential immunomodulatory effects on CD38-expressing cells, primarily plasma cells, as they have a key role in antibody production. In particular there is interest in use of daratumumab for desensitization and potential treatment for antibody-mediated rejection. However, ongoing investigation with daratumumab has shown potential immunologic concerns in vitro, with a significant increase in populations of CD4-positive cytotoxic T cells and CD8-positive helper T cells in both peripheral blood and bone marrow that could lead to acute T cell-mediated rejection in the solid organ transplant patient. To date, there are no published reports of an association with daratumumab use and T cell-mediated rejection in vivo. In this case report we present what is to our knowledge the first documented case of an early severe T cell-mediated rejection in a low-immunologic-risk living-donor kidney transplant recipient who received daratumumab for multiple myeloma maintenance prior to transplant. |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mesh-Begriff(e) | Humans ; Kidney Transplantation ; ADP-ribosyl Cyclase 1 ; Antibodies, Monoclonal/therapeutic use ; Multiple Myeloma/therapy ; T-Lymphocytes | ||||||||||
| Chemische Substanzen | daratumumab (4Z63YK6E0E) ; ADP-ribosyl Cyclase 1 (EC 3.2.2.6) ; Antibodies, Monoclonal | ||||||||||
| Sprache | Englisch | ||||||||||
| Erscheinungsdatum | 2023-01-06 | ||||||||||
| Erscheinungsland | United States | ||||||||||
| Dokumenttyp | Case Reports ; Research Support, Non-U.S. Gov't | ||||||||||
| ZDB-ID | 604539-x | ||||||||||
| ISSN | 1523-6838 ; 0272-6386 | ||||||||||
| ISSN (online) | 1523-6838 | ||||||||||
| ISSN | 0272-6386 | ||||||||||
| DOI | 10.1053/j.ajkd.2022.11.010 | ||||||||||
| Signatur |
|
||||||||||
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 1669: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 468: Hefte anzeigen |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.